Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
Main Authors: | Timothy Arthur Chandos Snow, Antonio Cesar, Mervyn Singer, Nishkantha Arulkumaran |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Critical Care |
Online Access: | https://doi.org/10.1186/s13054-022-04104-y |
Similar Items
-
Immunophenotyping patients with sepsis and underlying haematological malignancy reveals defects in monocyte and lymphocyte function
by: Timothy Arthur Chandos Snow, et al.
Published: (2024-01-01) -
INTRAVENOUS CLARITHROMYCIN: A VALUABLE IMMUNOMODULATOR FOR SEVERE INFECTIONS
by: Leventogiannis Konstantinos, et al.
Published: (2014-04-01) -
Intravenous clarithromycin: A valuable immunomodulator for severe infections
by: Leventogiannis Konstantinos, et al.
Published: (2014-01-01) -
Creating complex protocells and prototissues using simple DNA building blocks
by: Nishkantha Arulkumaran, et al.
Published: (2023-03-01) -
Purinergic Signalling in Inflammatory Renal Disease
by: Nishkantha eArulkumaran, et al.
Published: (2013-07-01)